Literature DB >> 15895299

alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.

Mie Sone1, Mari Yoshida, Yoshio Hashizume, Nozomi Hishikawa, Gen Sobue.   

Abstract

We immunohistochemically examined the sympathetic ganglia (SG) and brains of 26 patients with multiple system atrophy (MSA), 19 age-matched controls, and 25 patients with amyotrophic lateral sclerosis (ALS). alpha-Synuclein-immunoreactive structures were found in the neuronal cytoplasm and processes of the SG in 11 of the 26 MSA cases (42.3%) and 1 of the 25 ALS cases (4%), but not in the 19 controls. No alpha-synuclein-immunoreactive structures were found in Schwann cells or the neuronal nucleus. Mean disease duration of MSA cases with alpha-synuclein-immunoreactive structures was significantly longer than that of MSA cases without alpha-synuclein-immunoreactive structures. alpha-Synuclein-immunoreactive structures in 4 cases proved to be Lewy bodies (LB) based on hematoxylin-eosin staining. A few LB were also found in the brains of 3 of these 4 cases. In the other 7 MSA cases, diffuse or focal neuronal cytoplasmic aggregates and swollen neurites were detected with alpha-synuclein immunostaining, but not with hematoxylin-eosin staining. However, a few LB-like structures with ring-like staining were observed in those aggregates, which suggested those aggregates had progressed to form LB. Immunoelectron microscopically, those aggregates were composed of filaments and granular materials which closely resembled the ultrastructural features of LB. We inferred that alpha-synuclein aggregates found in the SG in our study evidenced LB-related pathologies. MSA, a type of synucleinopathy, is characterized by glial cytoplasmic inclusions in oligodendrocytes, but also frequently develops LB pathology in the late stage, especially in the SG.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895299     DOI: 10.1007/s00401-005-1013-9

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy.

Authors:  Kurt Kimpinski; Valeria Iodice; Duane D Burton; Michael Camilleri; Brian P Mullan; Axel Lipp; Paola Sandroni; Tonette L Gehrking; David M Sletten; J E Ahlskog; Robert D Fealey; Wolfgang Singer; Phillip A Low
Journal:  J Neurol Sci       Date:  2012-03-14       Impact factor: 3.181

Review 2.  Imaging the Autonomic Nervous System in Parkinson's Disease.

Authors:  Karoline Knudsen; Per Borghammer
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-19       Impact factor: 5.081

Review 3.  Neuropathobiology of non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2015-05-15       Impact factor: 3.575

4.  Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease.

Authors:  Kateri J Spinelli; Jonathan K Taylor; Valerie R Osterberg; Madeline J Churchill; Eden Pollock; Cynthia Moore; Charles K Meshul; Vivek K Unni
Journal:  J Neurosci       Date:  2014-02-05       Impact factor: 6.167

Review 5.  Neuroinflammation in Neurodegenerative Disorders-a Review.

Authors:  Martin Schain; William Charles Kreisl
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

6.  Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.

Authors:  Iñigo Gabilondo; Verónica Llorens; Trinidad Rodriguez; Manuel Fernández; Tomas Pérez Concha; Marian Acera; Beatriz Tijero; Ane Murueta-Goyena; Rocío Del Pino; Jesús Cortés; Juan Carlos Gómez-Esteban
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-15       Impact factor: 9.236

7.  Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study.

Authors:  Vincenzo Provitera; Valeria Iodice; Fiore Manganelli; Stefania Mozzillo; Giuseppe Caporaso; Annamaria Stancanelli; Ilaria Borreca; Marcello Esposito; Raffaele Dubbioso; Rosa Iodice; Floriana Vitale; Shiwen Koay; Ekawat Vichayanrat; Fernanda Valerio; Lucio Santoro; Maria Nolano
Journal:  Neurology       Date:  2022-01-11       Impact factor: 9.910

Review 8.  Multiple system atrophy: pathogenic mechanisms and biomarkers.

Authors:  Kurt A Jellinger; Gregor K Wenning
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

Review 9.  Recent developments in multiple system atrophy.

Authors:  Gregor K Wenning; Nadia Stefanova
Journal:  J Neurol       Date:  2009-05-27       Impact factor: 4.849

Review 10.  [Differential diagnostics of Parkinson's disease with nuclear medicine procedures].

Authors:  P T Meyer; F Amtage; S Hellwig
Journal:  Nervenarzt       Date:  2014-06       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.